Allen R C, Bauer V J, Kosley R W, McFadden A R, Shutske G M, Cornfeldt M L, Fielding S, Geyer H M, Wilker J C
J Med Chem. 1978 Nov;21(11):1149-54. doi: 10.1021/jm00209a012.
The synthesis of 1'-[3-(4-fluorobenzyoyl)propyl]-3-phenylspiro[isobenzofuran-1(3H),4'-piperidine] (2a) and eight halo and methoxy analogues is described. The compounds were generally more potent per os than chlorpromazine in the Sidman avoidance paradigm in rats and less potent than haloperido. 1'-[3-(4-Fluorobenzoyl)propyl]-3-(4-fluorophenyl)spiro[isobenzofuran-1(3H),4'-piperidine] (2e) approached the per os potency of haloperidol in this test and was shown to be active in inhibiting monkey avoidance also. Compound 2e was much less active than haloperidol in antagonizing apomorphine-induced emesis in dogs, apomorphine-induced stereotypy in rats, and amphetamine-induced circling in lesioned rats. This lack of nonselective, dopamine-receptor blocking effects makes 2e attrative as a potential neuroleptic.
本文描述了1'-[3-(4-氟苯甲酰基)丙基]-3-苯基螺异苯并呋喃-1(3H),4'-哌啶及八个卤代和甲氧基类似物的合成。在大鼠的西德曼回避范式中,这些化合物口服给药时通常比氯丙嗪更有效,且比氟哌啶醇效力低。在该试验中,1'-[3-(4-氟苯甲酰基)丙基]-3-(4-氟苯基)螺异苯并呋喃-1(3H),4'-哌啶接近氟哌啶醇的口服效力,并且在抑制猴子回避行为方面也表现出活性。在拮抗犬阿扑吗啡诱导的呕吐、大鼠阿扑吗啡诱导的刻板行为以及损伤大鼠中安非他明诱导的转圈行为方面,化合物2e的活性远低于氟哌啶醇。这种缺乏非选择性多巴胺受体阻断作用的特性使得2e作为一种潜在的抗精神病药物具有吸引力。